Madrid es Noticia – Gregorio Marañón Develops a Pioneering Treatment Against Transplant Rejection
A research team at Hospital General Universitario Gregorio Marañón has developed a world-pioneering cell-based treatment designed to prevent transplant rejection. The technique is already being used to treat three infant heart transplant recipients, all of whom are progressing favorably. The treatment, developed entirely at this public Madrid hospital over the past six years, helps prevent […]
Gaceta Médica – Marañón Discovers a World-Unique “Escape Route” Against Transplant Rejection
It is a cell therapy that “rescues” Treg cells from thymic tissue, helping to regulate the immune response in a sustained manner. Although organ transplantation is one of medicine’s greatest achievements and has saved thousands of lives, it is not a definitive solution because of immune rejection. As a result, most transplanted organs last fewer […]
20 minutos – Three Babies Receive Heart Transplants with a World-Pioneering Cell Therapy to Prevent Rejection
The transplant was performed at Hospital General Universitario Gregorio Marañón, making it a global pioneer. All three babies are evolving “favorably.” For the first time, thymus-derived Treg cells are being used, potentially prolonging the survival of the transplanted organ and the life of the patient. A team of researchers at Gregorio Marañón Hospital in the […]
Madridpress – Marañón Develops a Cell Therapy That Could Prevent Organ Transplant Rejection
Researchers at Hospital General Universitario Gregorio Marañón have developed a world-pioneering cell-based treatment to prevent organ transplant rejection. According to the Madrid hospital’s scientists, the therapy may regulate the immune system’s response and prevent rejection. The treatment, the result of more than six years of research carried out entirely at Gregorio Marañón, could completely inhibit […]
Con Salud – Marañón Develops a Pioneering Cell Therapy to Prevent Transplant Rejection
The treatment uses thymus-derived regulatory T cells (Treg) to regulate the immune system’s response and prevent rejection. Researchers at Hospital General Universitario Gregorio Marañón have developed a world-pioneering therapy to prevent immune rejection in organ transplantation. The approach is based on thyTreg cells, as explained by the hospital. Over six years, the hospital’s Immunoregulation Laboratory, […]
Vivir Ediciones – The Community of Madrid Develops at Gregorio Marañón Hospital a World-Pioneering Cell Therapy to Prevent Transplant Rejection
Three babies who have undergone heart transplants are already being treated with this technique and are progressing favorably. Researchers at Hospital General Universitario Gregorio Marañón, part of the public hospital network of the Community of Madrid, have independently developed a world-unique treatment to prevent immune rejection and potentially extend indefinitely the survival of transplanted organs […]
Gacetín Madrid – Madrid Develops a World-Pioneering Treatment to Prevent Transplant Rejection
Researchers at Hospital General Universitario Gregorio Marañón, part of the public hospital network of the Community of Madrid, have independently developed a world-unique treatment to prevent immune rejection and potentially extend indefinitely the survival of transplanted organs — and therefore the lives of patients. The team from the hospital’s Immunoregulation Laboratory, responsible for this pioneering […]
El Imparcial – Marañón Develops a Pioneering Technique to Prevent Organ Transplant Rejection
Most transplanted organs last fewer than 20 years and, therefore, are not lifelong solutions. In an effort to extend graft survival, Hospital General Universitario Gregorio Marañón has conducted research that has yielded promising results. To make transplanted organs last a lifetime, a team at the Madrid hospital has developed a new therapy aimed at reducing […]
Diario Médico – A Baby Receives Cell Therapy for the First Time in the World to Prevent Graft Rejection
Thymus-Derived Cell Therapy Prevents Transplanted Organ Rejection and Reduces Immunosuppression Requirements. More info: diariomedico.com
servimedia – Cell Therapy Developed to Prevent Organ Transplant Rejection
Researchers at Hospital General Universitario Gregorio Marañón have developed a world-pioneering cell-based therapy to prevent immune rejection in organ transplantation and potentially extend indefinitely the survival of transplanted organs — and therefore the lives of patients. Three infants are already being treated at the hospital. The therapy and underlying technology were developed by the hospital’s […]
